Ovarian Cancer: Optimizing the Management Based on Mutations and Biomarkers to Direct Treatment with PARP Inhibitors and Immunotherapy
7/10/24 - 7/10/25
https://www.mycme.com/courses/ovarian-cancer-mutations-biomarkers-treatment-parp-inhibitors-immunotherapy-9558

Changing Landscape of Diagnosis and Treatment Options for Multiple Myeloma
11/16/23 - 11/16/24
https://www.mycme.com/courses/diagnosis-and-treatment-options-for-multiple-myeloma-9155

Emerging Strategies in the Immune Checkpoint Inhibitors (ICIs) and the Synergistic Effect of Antibody-Drug Conjugate in Combination with ICIs for Urothelial Carcinoma
4/18/23 - 4/18/24
https://www.mycme.com/courses/immune-checkpoint-inhibitors-antibody-drug-combination-urothelial-carcinoma-8758

Hepatocellular Carcinoma: Immune Checkpoint Inhibitors, Multi-Targeted Tyrosine Kinase Inhibitors and the Combination Thereof
2/9/23 - 2/9/24
https://www.mycme.com/courses/novel-therapies-for-hepatocellular-carcinoma-8614

New Strategies in the Diagnosis and Treatment of Follicular Lymphoma: 2022 ASH Update
12/30/22 - 12/30/23
https://www.mycme.com/courses/novel-therapies-for-follicular-lymphoma-8569

Advances in Symptom Burden, Risk Stratification and Treatment of Myelofibrosis
1/25/23 - 1/25/24
https://www.mycme.com/courses/advances-in-the-diagnosis-and-treatment-of-myelofibrosis-8595

Emerging Strategies in the Treatment of Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma
12/8/22 - 12/8/23
https://www.mycme.com/courses/treatment-strategies-for-genitourinary-cancers-8530

Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy
10/21/22 - 10/21/23
https://www.mycme.com/courses/ovarian-cancer-mutations-biomarkers-treatment-parp-inhibitors-immunotherapy-8460

Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma
9/14/22 - 9/14/23
https://www.mycme.com/courses/immune-checkpoint-braf-mek-inhibitor-therapies-advanced-melanoma-8416

Improving Renal Cell Carcinoma Patient Outcomes with Multi-targeted TKIs and Immune Checkpoint Inhibitors
9/12/22 - 9/12/23
https://www.mycme.com/courses/renal-cell-carcinoma-outcomes-multi-targeted-tkis-immune-checkpoint-inhibitors-8409

New and Emerging Treatment Options for CLL/SLL and MCL
6/24/22 - 6/24/23
https://www.mycme.com/courses/emerging-treatment-options-for-chronic-lymphocytic-leukemia-and-mantle-cell-lymphoma-8304

Current and New Biomarkers and Targeted Therapy Options for Gastric and Gastroesophageal Junction Cancers
5/20/22 - 5/20/23
https://www.mycme.com/courses/new-biomarkers-and-targeted-therapy-options-for-gastric-cancer-8254

Current and Emerging Treatment Options for Multiple Myeloma
4/7/22 - 4/7/23
https://www.mycme.com/courses/current-and-emerging-treatment-options-for-multiple-myeloma-8161

Novel Treatment Options for Multiple Myeloma
3/23/22 - 3/23/23
https://www.mycme.com/courses/novel-treatment-options-for-multiple-myeloma-8130

New and Emerging Treatment Options for Hematological Malignancies
12/30/21 - 12/30/22
https://www.mycme.com/courses/novel-therapies-for-hematological-malignancies-8044

Evolving Strategies in the Treatment of HER2-positive Metastatic Breast Cancer with Antibody-Drug Conjugates and Tyrosine Kinase Inhibitors
12/8/21 - 12/8/22
https://www.mycme.com/courses/her2-positive-metastatic-breast-cancer-treatment-7986

Emerging Strategies in the Management of Genitourinary Cancers
11/22/21 - 11/22/22
https://www.mycme.com/courses/novel-therapies-for-genitourinary-cancers-7958

Novel Therapies for Metastatic Castrate Resistant Prostate Cancer with PARP-Inhibitors and BITE Immunotherapy
Live Virtual Webinar
October 6, 2021, 7pm - 8:30pm EDT
Rebroadcast: October 20, 2021, 2021, 7pm - 8:30pm EDT

Emerging Treatment Options for BRAF-mutant Colorectal Cancer
Live Virtual Webinar
August 18, 2021, 7pm - 8:30pm EDT
Rebroadcast: August 26, 2021, 7pm - 8:30pm EDT

Changing Landscape of Treatment for Acute Lymphoblastic Leukemia
Live Virtual Webinar